536 related articles for article (PubMed ID: 31131821)
1. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Yang L; Gong N; Zhou H; Jiang J
Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Liu J; Huang X; Liu Y; Xu H; Gong R; Li C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1328-1333. PubMed ID: 28070047
[TBL] [Abstract][Full Text] [Related]
3. Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Hui-Min Y; Yan-Ping W; Lin Liu Y; Shamsi BH; Bo H; Xu-Chun M
J Int Med Res; 2018 Jan; 46(1):225-233. PubMed ID: 28789605
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic spectrum and risk factors of peritoneal dialysis-associated peritonitis: a single-center retrospective study.
You L; Zhang B; Zhang F; Wang J
BMC Infect Dis; 2024 Apr; 24(1):440. PubMed ID: 38658811
[TBL] [Abstract][Full Text] [Related]
5. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility.
Persy B; Ieven M
Acta Clin Belg; 2013; 68(1):48-53. PubMed ID: 23627195
[TBL] [Abstract][Full Text] [Related]
6. Use of cefazolin for peritonitis treatment in peritoneal dialysis patients.
Agraharkar M; Klevjer-Anderson P; Rubinstien E; Galen M
Am J Nephrol; 1999; 19(5):555-8. PubMed ID: 10575183
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenic bacteria and drug resistance in peritoneal dialysis related peritonitis].
Peng W; Zhou Q; Ao X; Tang R; Li X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1205-9. PubMed ID: 23281370
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis-related infections recommendations: 2016 update. What is new?
Liakopoulos V; Nikitidou O; Kalathas T; Roumeliotis S; Salmas M; Eleftheriadis T
Int Urol Nephrol; 2017 Dec; 49(12):2177-2184. PubMed ID: 28573488
[TBL] [Abstract][Full Text] [Related]
9. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.
Ghali JR; Bannister KM; Brown FG; Rosman JB; Wiggins KJ; Johnson DW; McDonald SP
Perit Dial Int; 2011; 31(6):651-62. PubMed ID: 21719685
[TBL] [Abstract][Full Text] [Related]
10. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis.
Lee CC; Sun CY; Chang KC; Wu MS
Ther Apher Dial; 2010 Apr; 14(2):201-8. PubMed ID: 20438543
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.
Lin WH; Tseng CC; Wu AB; Chang YT; Kuo TH; Chao JY; Wang MC; Wu JJ
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1699-1707. PubMed ID: 29931659
[TBL] [Abstract][Full Text] [Related]
12. Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Oliveira LG; Luengo J; Caramori JC; Montelli AC; Cunha Mde L; Barretti P
Int Urol Nephrol; 2012 Oct; 44(5):1529-37. PubMed ID: 22302733
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gram-positive peritonitis in peritoneal dialysis patients: cefazolin or vancomycin?
Lévesque R; Lemieux C; Laverdière M; Pichette V
Perit Dial Int; 2003; 23(6):599-601. PubMed ID: 14703205
[No Abstract] [Full Text] [Related]
14. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of organisms causing peritonitis in peritoneal dialysis patients--experience from Bangladesh.
Iqbal MM; Sattar H; Islam MN; Ahmed AH; Rahman MH; Rashid HU; Mohsi M
Adv Perit Dial; 2008; 24():40-3. PubMed ID: 18985999
[TBL] [Abstract][Full Text] [Related]
16. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan.
Wang HH; Huang CH; Kuo MC; Lin SY; Hsu CH; Lee CY; Chiu YW; Chen YH; Lu PL
J Microbiol Immunol Infect; 2019 Oct; 52(5):752-759. PubMed ID: 30665844
[TBL] [Abstract][Full Text] [Related]
17. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Heywood A; Bargman JM
Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
[TBL] [Abstract][Full Text] [Related]
18. The need for a center-tailored treatment protocol for peritonitis.
Van Biesen W; Vanholder R; Vogelaers D; Peleman R; Verschraegen G; Vijt D; Lameire N
Perit Dial Int; 1998; 18(3):274-81. PubMed ID: 9663891
[TBL] [Abstract][Full Text] [Related]
19. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial.
Restrepo C; Chacon J; Manjarres G
Perit Dial Int; 2010; 30(6):619-25. PubMed ID: 20634438
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]